Recent ATHE News
- Alterity Therapeutics Raises Profile with Multiple Data Presentations at the International Congress of Parkinson’s Disease and Movement Disorders® • GlobeNewswire Inc. • 10/02/2024 11:35:00 AM
- Alterity Therapeutics Appoints Abby Macnish Niven as Chief Financial Officer • GlobeNewswire Inc. • 09/30/2024 11:35:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/23/2024 12:00:19 PM
- Alterity Therapeutics to Deliver Multiple Oral and Poster Presentations at the International Congress of Parkinson’s Disease and Movement Disorders® • GlobeNewswire Inc. • 09/23/2024 11:35:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/29/2024 10:07:27 AM
- Appendix 4C – Q4 FY24 Quarterly Cash Flow Report • GlobeNewswire Inc. • 07/31/2024 11:35:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/31/2024 10:23:35 AM
- Alterity Therapeutics to Present at MST Financial Webinar • GlobeNewswire Inc. • 07/24/2024 11:35:00 AM
- Alterity Therapeutics Reports Positive Interim Data from ATH434-202 Phase 2 Clinical Trial in Multiple System Atrophy • GlobeNewswire Inc. • 07/17/2024 11:35:00 AM
- Alterity Therapeutics Reports Positive Interim Data from ATH434-202 Phase 2 Clinical Trial in Multiple System Atrophy • GlobeNewswire Inc. • 07/17/2024 11:25:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/13/2024 12:28:27 PM
- Alterity Therapeutics to Present at the MST Access ‘Hidden Gems in Life Sciences’ Webinar • GlobeNewswire Inc. • 06/12/2024 11:22:16 PM
- Alterity Therapeutics to Host Webcast Today on New Data from the bioMUSE Natural History Study • GlobeNewswire Inc. • 05/29/2024 11:21:24 PM
- Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned After Third Review • GlobeNewswire Inc. • 05/08/2024 11:25:00 AM
- Appendix 4C – Q3 FY24 Quarterly Cash Flow Report • GlobeNewswire Inc. • 04/30/2024 11:25:00 AM
- Alterity Therapeutics Presents New Data Demonstrating Potential of ATH434 to Treat Rare Neurodegenerative Disease Friedreich’s Ataxia • GlobeNewswire Inc. • 04/29/2024 11:25:00 AM
- Alterity Therapeutics Parkinson’s Disease and Multiple System Atrophy Data Featured at the American Academy of Neurology (AAN) 2024 Annual Meeting • GlobeNewswire Inc. • 04/17/2024 11:25:00 AM
- Alterity Therapeutics to Present New Data on ATH434 at the World Orphan Drug Congress USA 2024 • GlobeNewswire Inc. • 04/10/2024 11:25:00 AM
- Alterity Therapeutics Receives a A$3.9 Million Research & Development Tax Incentive Refund • GlobeNewswire Inc. • 03/26/2024 02:25:00 PM
- Alterity Therapeutics to Present New Data at the Upcoming American Academy of Neurology 2024 Annual Meeting • GlobeNewswire Inc. • 02/20/2024 03:25:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/15/2024 10:29:14 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/15/2024 10:28:37 PM
- Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned After Second Review • GlobeNewswire Inc. • 02/06/2024 12:25:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/31/2024 01:00:15 PM
- Alterity Therapeutics to Participate in the ShareCafe Hidden Gems Webinar This Week • GlobeNewswire Inc. • 01/29/2024 12:24:00 PM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM
Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM
Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM
Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • NGTF • Oct 1, 2024 8:30 AM
ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • COOP • Oct 1, 2024 7:00 AM
Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM